The global Interventional Oncology market size was valued at US$ 1652.5 million in 2023. With growing demand in downstream market, the Interventional Oncology is forecast to a readjusted size of US$ 2181.3 million by 2030 with a CAGR of 4.0% during review period.
The research report highlights the growth potential of the global Interventional Oncology market. Interventional Oncology are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Interventional Oncology. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Interventional Oncology market.
Interventional oncology is a subspecialty field of interventional radiology that deals with the diagnosis and treatment of cancerand cancer-related problems using targeted minimally invasive procedures performed under image guidance.
Interventional oncology has developed to a separate pillar of modern oncology and it employs X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to help guide miniaturized instruments (e.g. biopsy needles, ablation electrodes, intravascular catheters) to allow targeted and precise treatment of solid tumours located in various organs of the human body, including but not limited to the liver, kidneys, lungs, and bones. Interventional oncology treatments are routinely carried out by interventional radiologists in appropriate settings and facilities.
Key Features:
The report on Interventional Oncology market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Interventional Oncology market. It may include historical data, market segmentation by Type (e.g., Ablation Devices, Embolization Devices), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Interventional Oncology market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Interventional Oncology market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Interventional Oncology industry. This include advancements in Interventional Oncology technology, Interventional Oncology new entrants, Interventional Oncology new investment, and other innovations that are shaping the future of Interventional Oncology.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Interventional Oncology market. It includes factors influencing customer ' purchasing decisions, preferences for Interventional Oncology product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Interventional Oncology market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Interventional Oncology market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Interventional Oncology market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Interventional Oncology industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Interventional Oncology market.
Market Segmentation:
Interventional Oncology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Ablation Devices
Embolization Devices
Support Devices
Segmentation by application
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Baylis Medical
Bovie Medical
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
Microsulis Medical
Monteris Medical
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Interventional Oncology Market Size 2019-2030
2.1.2 Interventional Oncology Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Interventional Oncology Segment by Type
2.2.1 Ablation Devices
2.2.2 Embolization Devices
2.2.3 Support Devices
2.3 Interventional Oncology Market Size by Type
2.3.1 Interventional Oncology Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Interventional Oncology Market Size Market Share by Type (2019-2024)
2.4 Interventional Oncology Segment by Application
2.4.1 Liver Cancer
2.4.2 Lung Cancer
2.4.3 Kidney Cancer
2.4.4 Bone Cancer
2.4.5 Breast Cancer
2.4.6 Prostate Cancer
2.4.7 Pancreatic Cancer
2.5 Interventional Oncology Market Size by Application
2.5.1 Interventional Oncology Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Interventional Oncology Market Size Market Share by Application (2019-2024)
3 Interventional Oncology Market Size by Player
3.1 Interventional Oncology Market Size Market Share by Players
3.1.1 Global Interventional Oncology Revenue by Players (2019-2024)
3.1.2 Global Interventional Oncology Revenue Market Share by Players (2019-2024)
3.2 Global Interventional Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Interventional Oncology by Regions
4.1 Interventional Oncology Market Size by Regions (2019-2024)
4.2 Americas Interventional Oncology Market Size Growth (2019-2024)
4.3 APAC Interventional Oncology Market Size Growth (2019-2024)
4.4 Europe Interventional Oncology Market Size Growth (2019-2024)
4.5 Middle East & Africa Interventional Oncology Market Size Growth (2019-2024)
5 Americas
5.1 Americas Interventional Oncology Market Size by Country (2019-2024)
5.2 Americas Interventional Oncology Market Size by Type (2019-2024)
5.3 Americas Interventional Oncology Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Interventional Oncology Market Size by Region (2019-2024)
6.2 APAC Interventional Oncology Market Size by Type (2019-2024)
6.3 APAC Interventional Oncology Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Interventional Oncology by Country (2019-2024)
7.2 Europe Interventional Oncology Market Size by Type (2019-2024)
7.3 Europe Interventional Oncology Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Interventional Oncology by Region (2019-2024)
8.2 Middle East & Africa Interventional Oncology Market Size by Type (2019-2024)
8.3 Middle East & Africa Interventional Oncology Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Interventional Oncology Market Forecast
10.1 Global Interventional Oncology Forecast by Regions (2025-2030)
10.1.1 Global Interventional Oncology Forecast by Regions (2025-2030)
10.1.2 Americas Interventional Oncology Forecast
10.1.3 APAC Interventional Oncology Forecast
10.1.4 Europe Interventional Oncology Forecast
10.1.5 Middle East & Africa Interventional Oncology Forecast
10.2 Americas Interventional Oncology Forecast by Country (2025-2030)
10.2.1 United States Interventional Oncology Market Forecast
10.2.2 Canada Interventional Oncology Market Forecast
10.2.3 Mexico Interventional Oncology Market Forecast
10.2.4 Brazil Interventional Oncology Market Forecast
10.3 APAC Interventional Oncology Forecast by Region (2025-2030)
10.3.1 China Interventional Oncology Market Forecast
10.3.2 Japan Interventional Oncology Market Forecast
10.3.3 Korea Interventional Oncology Market Forecast
10.3.4 Southeast Asia Interventional Oncology Market Forecast
10.3.5 India Interventional Oncology Market Forecast
10.3.6 Australia Interventional Oncology Market Forecast
10.4 Europe Interventional Oncology Forecast by Country (2025-2030)
10.4.1 Germany Interventional Oncology Market Forecast
10.4.2 France Interventional Oncology Market Forecast
10.4.3 UK Interventional Oncology Market Forecast
10.4.4 Italy Interventional Oncology Market Forecast
10.4.5 Russia Interventional Oncology Market Forecast
10.5 Middle East & Africa Interventional Oncology Forecast by Region (2025-2030)
10.5.1 Egypt Interventional Oncology Market Forecast
10.5.2 South Africa Interventional Oncology Market Forecast
10.5.3 Israel Interventional Oncology Market Forecast
10.5.4 Turkey Interventional Oncology Market Forecast
10.5.5 GCC Countries Interventional Oncology Market Forecast
10.6 Global Interventional Oncology Forecast by Type (2025-2030)
10.7 Global Interventional Oncology Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Boston Scientific
11.1.1 Boston Scientific Company Information
11.1.2 Boston Scientific Interventional Oncology Product Offered
11.1.3 Boston Scientific Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Boston Scientific Main Business Overview
11.1.5 Boston Scientific Latest Developments
11.2 BTG
11.2.1 BTG Company Information
11.2.2 BTG Interventional Oncology Product Offered
11.2.3 BTG Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BTG Main Business Overview
11.2.5 BTG Latest Developments
11.3 Medtronic
11.3.1 Medtronic Company Information
11.3.2 Medtronic Interventional Oncology Product Offered
11.3.3 Medtronic Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Medtronic Main Business Overview
11.3.5 Medtronic Latest Developments
11.4 Merit Medical
11.4.1 Merit Medical Company Information
11.4.2 Merit Medical Interventional Oncology Product Offered
11.4.3 Merit Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merit Medical Main Business Overview
11.4.5 Merit Medical Latest Developments
11.5 Terumo
11.5.1 Terumo Company Information
11.5.2 Terumo Interventional Oncology Product Offered
11.5.3 Terumo Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Terumo Main Business Overview
11.5.5 Terumo Latest Developments
11.6 Accuray
11.6.1 Accuray Company Information
11.6.2 Accuray Interventional Oncology Product Offered
11.6.3 Accuray Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Accuray Main Business Overview
11.6.5 Accuray Latest Developments
11.7 Alpinion Medical Systems
11.7.1 Alpinion Medical Systems Company Information
11.7.2 Alpinion Medical Systems Interventional Oncology Product Offered
11.7.3 Alpinion Medical Systems Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Alpinion Medical Systems Main Business Overview
11.7.5 Alpinion Medical Systems Latest Developments
11.8 Angiodynamics
11.8.1 Angiodynamics Company Information
11.8.2 Angiodynamics Interventional Oncology Product Offered
11.8.3 Angiodynamics Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Angiodynamics Main Business Overview
11.8.5 Angiodynamics Latest Developments
11.9 Atricure
11.9.1 Atricure Company Information
11.9.2 Atricure Interventional Oncology Product Offered
11.9.3 Atricure Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Atricure Main Business Overview
11.9.5 Atricure Latest Developments
11.10 Baylis Medical
11.10.1 Baylis Medical Company Information
11.10.2 Baylis Medical Interventional Oncology Product Offered
11.10.3 Baylis Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Baylis Medical Main Business Overview
11.10.5 Baylis Medical Latest Developments
11.11 Bovie Medical
11.11.1 Bovie Medical Company Information
11.11.2 Bovie Medical Interventional Oncology Product Offered
11.11.3 Bovie Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Bovie Medical Main Business Overview
11.11.5 Bovie Medical Latest Developments
11.12 Brainlab
11.12.1 Brainlab Company Information
11.12.2 Brainlab Interventional Oncology Product Offered
11.12.3 Brainlab Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Brainlab Main Business Overview
11.12.5 Brainlab Latest Developments
11.13 Bsd Medical
11.13.1 Bsd Medical Company Information
11.13.2 Bsd Medical Interventional Oncology Product Offered
11.13.3 Bsd Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Bsd Medical Main Business Overview
11.13.5 Bsd Medical Latest Developments
11.14 C. R. Bard
11.14.1 C. R. Bard Company Information
11.14.2 C. R. Bard Interventional Oncology Product Offered
11.14.3 C. R. Bard Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 C. R. Bard Main Business Overview
11.14.5 C. R. Bard Latest Developments
11.15 C2 Therapeutics
11.15.1 C2 Therapeutics Company Information
11.15.2 C2 Therapeutics Interventional Oncology Product Offered
11.15.3 C2 Therapeutics Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 C2 Therapeutics Main Business Overview
11.15.5 C2 Therapeutics Latest Developments
11.16 Cardiofocus
11.16.1 Cardiofocus Company Information
11.16.2 Cardiofocus Interventional Oncology Product Offered
11.16.3 Cardiofocus Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Cardiofocus Main Business Overview
11.16.5 Cardiofocus Latest Developments
11.17 Cook Medical
11.17.1 Cook Medical Company Information
11.17.2 Cook Medical Interventional Oncology Product Offered
11.17.3 Cook Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Cook Medical Main Business Overview
11.17.5 Cook Medical Latest Developments
11.18 Eckert And Ziegler Bebig
11.18.1 Eckert And Ziegler Bebig Company Information
11.18.2 Eckert And Ziegler Bebig Interventional Oncology Product Offered
11.18.3 Eckert And Ziegler Bebig Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Eckert And Ziegler Bebig Main Business Overview
11.18.5 Eckert And Ziegler Bebig Latest Developments
11.19 Edap Tms
11.19.1 Edap Tms Company Information
11.19.2 Edap Tms Interventional Oncology Product Offered
11.19.3 Edap Tms Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Edap Tms Main Business Overview
11.19.5 Edap Tms Latest Developments
11.20 Elekta
11.20.1 Elekta Company Information
11.20.2 Elekta Interventional Oncology Product Offered
11.20.3 Elekta Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Elekta Main Business Overview
11.20.5 Elekta Latest Developments
11.21 Galil Medical
11.21.1 Galil Medical Company Information
11.21.2 Galil Medical Interventional Oncology Product Offered
11.21.3 Galil Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Galil Medical Main Business Overview
11.21.5 Galil Medical Latest Developments
11.22 Healthtronics
11.22.1 Healthtronics Company Information
11.22.2 Healthtronics Interventional Oncology Product Offered
11.22.3 Healthtronics Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Healthtronics Main Business Overview
11.22.5 Healthtronics Latest Developments
11.23 Insightec
11.23.1 Insightec Company Information
11.23.2 Insightec Interventional Oncology Product Offered
11.23.3 Insightec Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Insightec Main Business Overview
11.23.5 Insightec Latest Developments
11.24 Medwaves
11.24.1 Medwaves Company Information
11.24.2 Medwaves Interventional Oncology Product Offered
11.24.3 Medwaves Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 Medwaves Main Business Overview
11.24.5 Medwaves Latest Developments
11.25 Mermaid Medical
11.25.1 Mermaid Medical Company Information
11.25.2 Mermaid Medical Interventional Oncology Product Offered
11.25.3 Mermaid Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Mermaid Medical Main Business Overview
11.25.5 Mermaid Medical Latest Developments
11.26 Microsulis Medical
11.26.1 Microsulis Medical Company Information
11.26.2 Microsulis Medical Interventional Oncology Product Offered
11.26.3 Microsulis Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.26.4 Microsulis Medical Main Business Overview
11.26.5 Microsulis Medical Latest Developments
11.27 Monteris Medical
11.27.1 Monteris Medical Company Information
11.27.2 Monteris Medical Interventional Oncology Product Offered
11.27.3 Monteris Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.27.4 Monteris Medical Main Business Overview
11.27.5 Monteris Medical Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
